Saat rata-rata pengikut agama Islam yagn ajarannnya dungu, buas, kejam, kej, 
ganas, zalim lagi biadab itu sibuk membuang-buang waktunya untuk zikir dan 
tungang tunggik kayak onta dientotin jirapah lima kali sehari menyembah Allah 
fiktif; saat ratusan ribu diantar mereka sibuk tiap tahun  membuang-buang duit 
unutk naik haji sembari lari-lari kayak orang sedeng di Makkah sono dan 
melempari setan yang nggak ada di padang pasir sono; saat mereka itu sibuk 
saling berbunuhan dan bikin onar....

Orang kafir tidak henti-hentinya melakukan penelitian untuk memajukan ilmu 
ketabiban dan berbagai cabang ilmu pengetahuan lain......


Cancer drug success 'on the rise'

Cancer drug research is entering a new era which will mean more successful 
drugs for patients, says a charity.

However, Cancer Research UK called for pharmaceutical firms and academics to be 
more open about those which do not make the grade.

Improved knowledge of cancer's biology means 18% of new drugs, compared to 5% 
previously - will become standard treatments, said the charity's experts.

Their research was published in the journal Nature Reviews Drug Discovery.

    We strongly believe that both industry and academia must improve the 
availability of data related to failed as well as successful drug development 
Professor Herbie Newell
Cancer Research UK

The hunt for cancer drugs is carried out on a massive scale, but there is also 
a massive failure rate, as promising candidates fall by the wayside in clinical 

This costs drug firms and charities such as Cancer Research UK many millions, 
although scientists can learn lessons even from expensive failures.

Some studies have estimated that, in the past, just 5% of cancer drugs in the 
pipeline actually end up in the clinic being used day to day.

Data on 974 drugs under development, gathered by Cancer Research UK experts, 
suggests that 18% of them will prove successful in clinical trials.

It is hoped that many of them will be alternatives to conventional 
chemotherapy, which can have unpleasant and dangerous side-effects, targeting 
the mechanisms of cancer cells more directly, with less damage to healthy cells.

Genetic make-up

Dr Ian Walker, the licensing manager at the charity's commercial development 
arm, said: "This clearly demonstrates the benefits of developing molecularly 
targeted treatments for cancer - understanding more about the basic biology of 
cancer is making a real difference to the success rate for new anti-cancer drug 

The ability to tailor drug choices to the genetic make-up of patients in some 
cases is also having a benefit.

However, Professor Herbie Newell, also from Cancer Research UK, said that 
minimising the number of "failures" - and their cost to the industry - would be 
vital, and this could be helped if researchers and drug companies were more 
open about what worked, and what did not:

"We strongly believe that both industry and academia must improve the 
availability of data related to failed as well as successful drug development 

"The sharing of such information can only be beneficial for clinical, 
scientific and commercial reasons - and will help measure our progress as well 
as pinpoint areas for improvement."

Story from BBC NEWS:

Published: 2008/11/16 00:00:22 GMT


Jusfiq Hadjar gelar Sutan Maradjo Lelo

Allah yang disembah orang Islam tipikal dan yang digambarkan oleh al-Mushaf itu 
dungu, buas, kejam, keji, ganas, zalim lagi biadab hanyalah Allah fiktif.


Kirim email ke